EFFICACY OF TOPIRAMATE AS ADD-ON THERAPY IN TWO DIFFERENT TYPES OF PROGRESSIVE MYOCLONIC EPILEPSY Cited by

Acta Medica > Archive > 2013, Vol. 56 > Issue 1 > p. 36 > Cited by

Acta Med. 2013, 56: 36-38

https://doi.org/10.14712/18059694.2014.37

Caner Feyzi Demir^a, Hasan Hüseyin Özdemir^b, Bülent Müngen^a

^aDepartment of Neurology, Fırat (Euphrates) University, Elazıg, Turkey
^bBismil State Hospital, Neurology, Diyarbakır, Turkey

Stahl Christine M., Frucht Steven J.: An Update on Myoclonus Management. Expert Review of Neurotherapeutics 2019, 19, 325. <https://doi.org/10.1080/14737175.2019.1592676>
Mills Kelly, Mari Zoltan: An Update and Review of the Treatment of Myoclonus. Curr Neurol Neurosci Rep 2015, 15. <https://doi.org/10.1007/s11910-014-0512-2>
Malek N., Stewart W., Greene J.: The progressive myoclonic epilepsies. Practical Neurology 2015, 15, 164. <https://doi.org/10.1136/practneurol-2014-000994>
Yang Lin, Huang Shao-ping, Liu Yu, Wang Xue-ying, Li Dan: Short-term use of antiepileptic drugs is neurotoxic to the immature brain. Neural Regen Res 2015, 10, 599. <https://doi.org/10.4103/1673-5374.155434>